ATE536880T1 - Impfstoff beinhaltend amb a 1 peptide zur behandlung von traubenkraut-allergie - Google Patents

Impfstoff beinhaltend amb a 1 peptide zur behandlung von traubenkraut-allergie

Info

Publication number: ATE536880T1
Authority: AT; Austria
Prior art keywords: allergy; rape; peptides; treatment; ragweed
Prior art date: 2008-08-15

Application number

AT09251252T

Other languages

English (en)

Inventor

Mark Larche

Roderick Peter Hafner

Paul Laidler

Original Assignee

Circassia Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-08-15

Filing date

2009-05-01

Publication date

2011-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41090318&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE536880(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-08-15 Priority claimed from GB0814986A external-priority patent/GB0814986D0/en

2008-08-20 Priority claimed from GB0815218A external-priority patent/GB0815218D0/en

2009-05-01 Application filed by Circassia Ltd filed Critical Circassia Ltd

2011-12-15 Application granted granted Critical

2011-12-15 Publication of ATE536880T1 publication Critical patent/ATE536880T1/de

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
206010020751 Hypersensitivity Diseases 0.000 title abstract 2
208000026935 allergic disease Diseases 0.000 title abstract 2
230000007815 allergy Effects 0.000 title abstract 2
229960005486 vaccine Drugs 0.000 title 1
239000000203 mixture Substances 0.000 abstract 3
244000036975 Ambrosia artemisiifolia Species 0.000 abstract 2
235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 abstract 2
239000013566 allergen Substances 0.000 abstract 2
235000003484 annual ragweed Nutrition 0.000 abstract 2
235000006263 bur ragweed Nutrition 0.000 abstract 2
235000003488 common ragweed Nutrition 0.000 abstract 2
229920001184 polypeptide Polymers 0.000 abstract 2
235000009736 ragweed Nutrition 0.000 abstract 2
102000007079 Peptide Fragments Human genes 0.000 abstract 1
108010033276 Peptide Fragments Proteins 0.000 abstract 1
210000001744 T-lymphocyte Anatomy 0.000 abstract 1
230000000172 allergic effect Effects 0.000 abstract 1
208000010668 atopic eczema Diseases 0.000 abstract 1
238000009472 formulation Methods 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000047 product Substances 0.000 abstract 1
239000009342 ragweed pollen Substances 0.000 abstract 1
230000004044 response Effects 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1
239000013598 vector Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/145—Rhabdoviridae, e.g. rabies virus, Duvenhage virus, Mokola virus or vesicular stomatitis virus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56972—White blood cells
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
Cell Biology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Microbiology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Tropical Medicine & Parasitology (AREA)
General Physics & Mathematics (AREA)
Physics & Mathematics (AREA)
Pathology (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Analytical Chemistry (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Mycology (AREA)
Toxicology (AREA)
Botany (AREA)
Zoology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)

AT09251252T 2008-08-15 2009-05-01 Impfstoff beinhaltend amb a 1 peptide zur behandlung von traubenkraut-allergie ATE536880T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB0814986A GB0814986D0 (en)	2008-08-15	2008-08-15	Peptide for il10 production
GB0815218A GB0815218D0 (en)	2008-08-20	2008-08-20	Ragweed peptides for vaccine

Publications (1)

Publication Number	Publication Date
ATE536880T1 true ATE536880T1 (de)	2011-12-15

Family

ID=41090318

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT09251252T ATE536880T1 (de)	2008-08-15	2009-05-01	Impfstoff beinhaltend amb a 1 peptide zur behandlung von traubenkraut-allergie

Country Status (18)

Country	Link
US (3)	US8491910B2 (de)
EP (3)	EP2153841B2 (de)
JP (1)	JP5788319B2 (de)
KR (1)	KR20110044787A (de)
CN (2)	CN102170897B (de)
AT (1)	ATE536880T1 (de)
AU (1)	AU2009281013B2 (de)
BR (1)	BRPI0917648A2 (de)
CA (1)	CA2734379A1 (de)
DK (1)	DK2153841T4 (de)
EA (1)	EA201170336A1 (de)
ES (1)	ES2378870T5 (de)
HR (1)	HRP20120206T4 (de)
MX (1)	MX2011001619A (de)
PL (1)	PL2153841T5 (de)
PT (1)	PT2153841E (de)
SI (1)	SI2153841T2 (de)
WO (1)	WO2010018378A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1958645A1 (de) *	2007-02-13	2008-08-20	Biomay AG	Peptide abgeleitet vom Hauptallergens von Traubenkraut (Ambrosia artemisiifolia) und deren Anwendung
EP2153841B2 (de) *	2008-08-15	2015-11-11	Circassia Limited	Impfstoff beinhaltend Amb a 1 Peptide zur Behandlung von Traubenkraut-Allergie
US8821887B2 (en) *	2008-08-15	2014-09-02	Circassia Limited	T-cell antigen peptide from allergen for stimulation of IL-10 production
CA2786936A1 (en) *	2010-01-14	2011-07-21	Merck Patent Gmbh	Variants of group 5 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues
FI20115374A0 (fi)	2011-04-18	2011-04-18	Teknologian Tutkimuskeskus Vtt Oy	Uudet hypoallergeenit
EP2723373B1 (de) *	2011-06-27	2017-06-21	Anergis S.A.	Überlappende angrenzende peptide zur behandlung einer ambrosienpollenallergie
JP2015514126A (ja) *	2012-04-16	2015-05-18	アルク−アベッロエイ／エスＡｌｋ−ＡｂｅｌｌｏＡ／Ｓ	非特異的アレルギー免疫療法において使用するための植物プロフィリンポリペプチド
NZ707615A (en)	2012-10-30	2019-01-25	Aravax Pty Ltd	Novel immunotherapeutic molecules and uses thereof
EP2968528B1 (de)	2013-03-15	2022-02-23	Sementis Limited	Immunmodulation
WO2015042664A1 (en)	2013-09-25	2015-04-02	Monash University	Novel immunotherapeutic composition and uses thereof
WO2017179025A1 (en)	2016-04-15	2017-10-19	Alk-Abelló A/S	Epitope polypeptides of ragweed pollen allergens
EP3295956A1 (de)	2016-09-20	2018-03-21	Biomay Ag	Polypeptidkonstrukt mit fragmenten von allergenen
CN117362453B (zh) *	2023-12-08	2024-02-27	山东硕景生物科技有限公司	一种Derf1重组抗原、其制备方法及应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5776761A (en) *	1989-03-17	1998-07-07	Immulogic Pharmaceutical Corporation	Nucleic acids encoding allergenic proteins from ragweed
EP0463059B1 (de)	1989-03-17	1998-12-30	Immulogic Pharmaceutical Corporation	Allergene proteine aus ambrosia und verwendung davon
US5703055A (en)	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
US5399346A (en)	1989-06-14	1995-03-21	The United States Of America As Represented By The Department Of Health And Human Services	Gene therapy
WO1994001560A1 (en)	1991-07-12	1994-01-20	Immulogic Pharmaceutical Corporation	Allergenic proteins and peptides from japanese cedar pollen
FI944697L (fi) *	1992-04-09	1994-12-07	Immulogic Pharma Corp	Ambrosia artemisiifolian pääallergeenien T-soluepitoopit
JPH07257419A (ja)	1994-03-24	1995-10-09	Kubota Corp	農作業車
US5968526A (en)	1994-04-14	1999-10-19	Immulogic Pharamaceutical Corporation	T cell epitopes of the major allergens from Dermatophagoides (house dust mite)
IL115744A (en)	1994-10-27	2000-07-16	Akzo Nobel Nv	Peptides comprising a subsequence of human cartilage glycoprotein - 39
WO1996013589A1 (en) *	1994-10-27	1996-05-09	Immulogic Pharmaceutical Corporation	T cell epitopes of the major allergens from ambrosia artemisiifolia
JP2002500198A (ja)	1998-01-09	2002-01-08	サーカシアリミテッド	脱感作のための方法及び組成物
US6989146B2 (en)	2000-08-09	2006-01-24	The Regents Of The University Of California	Stress proteins and peptides and methods of use thereof
WO2003047618A2 (en)	2001-12-05	2003-06-12	Circassia Limited	Immunotherapeutic methods and systems
AU2003228133A1 (en)	2002-04-22	2003-11-03	Umc Utrecht Holding B.V.	Reduction of unwanted immune reactions
GB0210741D0 (en)	2002-05-10	2002-06-19	Medical Res Council	Methods of therapy
GB0308988D0 (en)	2003-04-17	2003-05-28	Univ Singapore	Molecule
WO2006075253A2 (en)	2005-01-11	2006-07-20	Commissariat A L'energie Atomique	Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
KR20070110901A (ko) *	2005-03-04	2007-11-20	다이나박스 테크놀로지 코퍼레이션	항원에 콘쥬게이트되고 버퍼 조건 및 추가의 부형제들에의해 안정화된 면역자극성 서열(ｉｓｓ)을 갖는올리고뉴클레오티드를 포함하는 백신
WO2006132607A1 (en)	2005-06-10	2006-12-14	National University Of Singapore	Mutant allergen(s)
US20070092532A1 (en)	2005-10-25	2007-04-26	Board Of Trustees Operating Michigan State University	Arthritis vaccines and methods
CN100457180C (zh) *	2005-11-09	2009-02-04	浙江我武生物科技有限公司	用于治疗过敏性疾病的药物组合物及其制备方法
DK2119450T3 (da)	2005-11-29	2013-05-06	Actogenix Nv	Induktion af mucosal tolerance over for pankreatisk ø-beta-celle-autoantigener
AT503690A1 (de) *	2006-06-09	2007-12-15	Biomay Ag	Hypoallergene moleküle
EP1958645A1 (de)	2007-02-13	2008-08-20	Biomay AG	Peptide abgeleitet vom Hauptallergens von Traubenkraut (Ambrosia artemisiifolia) und deren Anwendung
US20110038881A1 (en)	2007-05-09	2011-02-17	Circassia Limited	Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation
GB0710529D0 (en)	2007-06-01	2007-07-11	Circassia Ltd	Vaccine
BRPI0815395A2 (pt)	2007-08-15	2015-02-10	Circassia Ltd	Composição, vetor, produto, formulação farmacêutica, me´todo in vitro para determinar se as células t reconhecem um polipeptídeo, e, método in vitro para determinar se um indivíduo se encontra ou está em risco de uma condição.
EP2153841B2 (de) *	2008-08-15	2015-11-11	Circassia Limited	Impfstoff beinhaltend Amb a 1 Peptide zur Behandlung von Traubenkraut-Allergie

2009
- 2009-05-01 EP EP09251252.4A patent/EP2153841B2/de not_active Not-in-force
- 2009-05-01 EP EP11187162A patent/EP2444100A3/de not_active Withdrawn
- 2009-05-01 ES ES09251252.4T patent/ES2378870T5/es active Active
- 2009-05-01 AT AT09251252T patent/ATE536880T1/de active
- 2009-05-01 PL PL09251252.4T patent/PL2153841T5/pl unknown
- 2009-05-01 DK DK09251252.4T patent/DK2153841T4/en active
- 2009-05-01 SI SI200930185T patent/SI2153841T2/sl unknown
- 2009-05-01 EP EP11187164A patent/EP2433639A3/de not_active Withdrawn
- 2009-05-01 PT PT09251252T patent/PT2153841E/pt unknown
- 2009-08-14 CN CN200980139316.6A patent/CN102170897B/zh not_active Expired - Fee Related
- 2009-08-14 BR BRPI0917648A patent/BRPI0917648A2/pt not_active IP Right Cessation
- 2009-08-14 WO PCT/GB2009/001986 patent/WO2010018378A2/en not_active Ceased
- 2009-08-14 KR KR1020117006048A patent/KR20110044787A/ko not_active Ceased
- 2009-08-14 MX MX2011001619A patent/MX2011001619A/es active IP Right Grant
- 2009-08-14 CA CA2734379A patent/CA2734379A1/en not_active Abandoned
- 2009-08-14 EA EA201170336A patent/EA201170336A1/ru unknown
- 2009-08-14 CN CN201510016302.2A patent/CN104710512A/zh active Pending
- 2009-08-14 AU AU2009281013A patent/AU2009281013B2/en not_active Ceased
- 2009-08-14 JP JP2011522549A patent/JP5788319B2/ja not_active Expired - Fee Related
- 2009-08-14 US US13/057,386 patent/US8491910B2/en not_active Expired - Fee Related
2012
- 2012-03-02 HR HRP20120206TT patent/HRP20120206T4/hr unknown
2013
- 2013-06-14 US US13/917,756 patent/US9347937B2/en not_active Expired - Fee Related
2016
- 2016-04-28 US US15/140,724 patent/US20170014505A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HRP20120206T4 (hr)	2016-02-12
US20120108524A1 (en)	2012-05-03
EP2153841A1 (de)	2010-02-17
US8491910B2 (en)	2013-07-23
EP2153841B1 (de)	2011-12-14
CA2734379A1 (en)	2010-02-18
AU2009281013B2 (en)	2015-01-29
SI2153841T1 (sl)	2012-04-30
PL2153841T5 (pl)	2016-09-30
DK2153841T4 (en)	2016-02-15
WO2010018378A8 (en)	2010-10-28
EP2444100A3 (de)	2012-07-25
CN102170897A (zh)	2011-08-31
SI2153841T2 (sl)	2016-02-29
EP2444100A2 (de)	2012-04-25
HRP20120206T1 (en)	2012-03-31
BRPI0917648A2 (pt)	2015-12-01
US20130295123A1 (en)	2013-11-07
KR20110044787A (ko)	2011-04-29
WO2010018378A2 (en)	2010-02-18
CN102170897B (zh)	2015-02-04
JP5788319B2 (ja)	2015-09-30
WO2010018378A3 (en)	2010-07-22
US20170014505A1 (en)	2017-01-19
JP2012500193A (ja)	2012-01-05
AU2009281013A1 (en)	2010-02-18
EP2433639A3 (de)	2012-06-27
EA201170336A1 (ru)	2011-10-31
ES2378870T5 (es)	2016-02-03
ES2378870T3 (es)	2012-04-18
CN104710512A (zh)	2015-06-17
US9347937B2 (en)	2016-05-24
MX2011001619A (es)	2011-03-25
PT2153841E (pt)	2012-03-21
EP2433639A2 (de)	2012-03-28
EP2153841B2 (de)	2015-11-11
PL2153841T3 (pl)	2012-05-31
DK2153841T3 (da)	2012-03-26

Publication	Publication Date	Title
HRP20120206T1 (en)	2012-03-31	Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy
Fuchs et al.	1997	Natural latex, grass pollen, and weed pollen share IgE epitopes
CY1123304T1 (el)	2021-12-31	Αναστολη πεπτιδιων που προερχονται απο μεταγραφημα 1 τυπου trem (tlt-1) και χρησεις αυτωn
EA200501017A1 (ru)	2006-02-24	Астма и модуляторы аллергических воспалений
EA201200515A1 (ru)	2012-10-30	Полипептиды и их применение
CY1112655T1 (el)	2016-02-10	Γλυκοζυλιωμενη ιl-7, παρασκευη και χρησεις
WO2004078777A3 (en)	2006-02-16	Dipeptidyl-peptidase protected proteins
MX2021011726A (es)	2021-10-22	Escindasas modificadas, usos de las mismas y kits relacionados.
WO2008124646A3 (en)	2009-04-02	Use of amyloid proteins as vaccine scaffolds
NZ594268A (en)	2013-05-31	Grass peptides for vaccine
EA202190310A1 (ru)	2021-07-01	Белок для лечения воспалительных заболеваний
ATE463512T1 (de)	2010-04-15	Identifizierung und charakterisierung von funktionsblockierenden anti-ed-b-fibronektin antikörpern
DE602006016133D1 (de)	2010-09-23	Verwendung von stefin a als gerüstprotein
MX2020012569A (es)	2021-02-18	Moleculas inmunoterapeuticas novedosas y sus usos.
EP3556857A3 (de)	2019-12-04	Cdc45l-peptide und impfstoffe damit
ATE552271T1 (de)	2012-04-15	Antitumorarzneimittel, medikament, zusammensetzung und anwendung davon
ATE400581T1 (de)	2008-07-15	Peptid-antioxidantien aus sojaproteinen
ES2550705T3 (es)	2015-11-11	Proteínas quiméricas hipoalergénicas pertenecientes a la familia de transferencia de lípidos de Parietaria judaica para usar en el tratamiento de alergias
Davies et al.	2011	The dominant 55 kDa allergen of the subtropical Bahia grass (Paspalum notatum) pollen is a group 13 pollen allergen, Pas n 13
WO2018200814A3 (en)	2018-12-06	Modified cyclic peptides and therapeutic use thereof
ATE473756T1 (de)	2010-07-15	Pharmazeutische zusammensetzung zur behandlung oder prävention von ovarialkrebs
IL177698A0 (en)	2006-12-31	Fusion proeins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same
WO2012073045A3 (en)	2012-09-27	Variants of trappins
WO2008070586A3 (en)	2008-10-16	Compositions and methods for treatment of protein misfolding and protein aggregation diseases
WO2016209959A2 (en)	2016-12-29	Peptide combinations and use thereof in treating cedar pollen allergy